Fox Chase Cancer Center

 

2019 Updates in Bladder and Kidney Cancer
15:00

Fox Chase Updates in Bladder and Kidney Cancer 2019

Controversies in Localized RCC: Is Taking a Drug for 12 Months and Being Exposed to AEs Worth Having 12 Months of Clean Scans w/o an OS Impact?

FEATURING Alexander Kutikov
  • 622 views
  • November 22, 2019
  • 3
13:52

Fox Chase Updates in Bladder and Kidney Cancer 2019

Role of Cytoreductive Nephrectomy in mRCC: Acceptable Morbidity Profile, Non-Receipt of Systemic Therapy, Role in IO Era Continues to Evolve

FEATURING Serge Ginzburg
  • 54 views
  • November 22, 2019
13:28

Fox Chase Updates in Bladder and Kidney Cancer 2019

Kidney Cancer Panel Discussion: Controversies in Localized Disease, Cytoreductive Nephrectomy in mRCC, and Advanced RCC

FEATURING Robert G. Uzzo
  • 42 views
  • November 22, 2019
13:44

Fox Chase Updates in Bladder and Kidney Cancer 2019

2019 Updates in the Management of Non-Muscle Invasive Bladder Cancer: Enhanced Cystoscopy, Urine Markers After Diagnosis, Chemotherapy Options and Checkpoint Inhibition

FEATURING J. Ryan Mark
  • 690 views
  • November 22, 2019
  • 2
13:40

Fox Chase Updates in Bladder and Kidney Cancer 2019

Muscle-Invasive Bladder Cancer: Who Are the Ideal Candidates for Bladder Preservation and How Do Outcomes Compare to Radical Cystectomy / Therapy for Patients w/ Medically Inoperable Disease and How to Improve Tolerability of Treatment?

FEATURING Mark A. Hallman
  • 440 views
  • November 22, 2019
  • 4
19:10

Fox Chase Updates in Bladder and Kidney Cancer 2019

2019 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma: Cisplatin as SoC, Pembro Mono as Alternative for Cis-Ineligible, Chemo +/- Atezolizumab vs. Atezolizumab Alone, Enfortumab Vedotin + Pembro, and Subsequent Therapies

FEATURING Elizabeth R. Plimack
  • 437 views
  • November 22, 2019
  • 4
15:42

Fox Chase Updates in Bladder and Kidney Cancer 2019

Bladder Cancer Panel Discussion: Management of Non-Muscle Invasive Bladder Cancer, Trimodality Therapy, 1st Line Systemic Therapy for Metastatic Urothelial Carcinoma

FEATURING Robert G. Uzzo
  • 129 views
  • November 22, 2019
22:18

Fox Chase Updates in Bladder and Kidney Cancer 2019

2019 Update on Advanced RCC: Who Needs Treatment, Which 1st Line Drug (Ipi/Nivo, TKI/IO, or TKI Alone), and How to Sequence After 1st Line?

FEATURING Daniel Geynisman
  • 1,540 views
  • December 16, 2019
  • 11